Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

Overview of attention for article published in Biologics in Therapy, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

twitter: 2 X users
patent: 1 patent

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

RETINAL DISORDERS

Application WO-2022263844-A1

World Intellectual Property Organisation (WIPO)